Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Osteosarcoma 4Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Recurrence 2Cardiotoxicity 2Breast Neoplasms 2Sezary Syndrome 1Sarcoma, Ewing 1Neuroectodermal Tumors, Primitive, Peripheral 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Leukemia, Biphenotypic, Acute 1Leukemia 1Intraocular Lymphoma 1Inflammatory Breast Neoplasms 1Immunoblastic Lymphadenopathy 1Hypersensitivity 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Blast Crisis 1

Interventions

Vincristine 2Temozolomide 2Irinotecan 2Doxorubicin 2Cyclophosphamide 2Bone Marrow Transplantation 2robatumumab 1pegfilgrastim 1palbociclib 1lexatumumab 1ganitumab 1disaccharide tripeptide 1delta 24-sterol reductase 1copanlisib 1bempegaldesleukin 1Thiotepa 1Radiosurgery 1Plicamycin 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Melphalan 1Magnetic Resonance Spectroscopy 1Interferon-gamma 1Immunotherapy, Adoptive 1INCB059872 1IL32 protein, human 1Granulocyte Colony-Stimulating Factor 1Genistein 1Filgrastim 1FANG vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Sarcoma, Ewing × Dexrazoxane × Clear all
NCT00038142 2020-01-29

Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients

M.D. Anderson Cancer Center

Phase 2 Terminated
46 enrolled 5 charts
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡